Jacob Painter, Pharm.D, Ph.D.


Research Health Scientist, Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System
Assistant Professor, Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences,


VA Phone: (501) 257-1740
VA Email: Jacob.Painter@va.gov
UAMS Phone: (501) 686-7123
UAMS Email: JTPainter@uams.edu

Research Expertise

Dr. Painter is a pharmacist and health services researcher. He received his Doctor of Pharmacy, Master of Business Administration, and Doctor of Philosophy (Pharmaceutical Outcomes & Policy) degrees from the University of Kentucky. His dissertational work examined the chronic opioid use in patients suffering from fibromyalgia. Since joining the VA, Dr. Painter’s research has focused on economic analysis of mental health approaches for Veterans including the “HIV Translating Initiatives for Depression Into Effective Solutions” and “Telemedicine Outreach for Post Traumatic Stress in CBOCs” interventions. He is especially interested in the interaction of mental health, pain, and the treatment choices associated with these conditions. Dr. Painter is an Assistant Professor in the Division of Pharmaceutical Evaluation & Policy at the UAMS College of Pharmacy. His responsibilities there include coordination of Pharmacy Management for professional students and Pharmacoepidemiology for graduate students.

Recent Publications

Current Publications (2009-2016)

  1. Painter JT, Moore G, Morris B. Addressing medication non-adherence through implementation of an appointment-based model synchronization network. America’s Pharmacist. Accepted: October 2015.
  2. Painter JT, Fortney JC, Gifford AL, Rimland D, Monson T, Rodriguez-Barradas MC, Pyne JM. Cost-effectiveness of Collaborative Care for Depression in Human Immunodeficiency Virus Clinics. Journal of Acquired Immune Deficiency Syndromes. Published ahead of print: June 2015.
  3. Lewis S, Painter JT, Price H, Stafford R. The Effect of Appointment-Based Medication Synchronization on Clinical Services in a Community Pharmacy. Computer Talk for the Pharmacist. 2015; 35(3): 15-18.
  4. Painter JT, Cobaugh DJ. Preventing Opioid Abuse: Prescription drug monitoring programs can play important role. Clinical and Forensic Toxicology News. March 2015. [Invited]
  5. Brown JD, Hutchinson LC, Li C, Painter JT, Martin BC. Predictive validity of the Beers and STOPP criteria to detect adverse drug events, hospitalizations, and emergency department visits in the United States. Journal of the American Geriatrics Society. Accepted: December 2014.
  6. Painter JT, Crofford LJ, Talbert J, Butler JS. Healthcare costs associated with chronic opioid use and fibromyalgia syndrome: a propensity-matched case control. American Journal of Pharmacy Benefits. 2014;6(6):e177-e184.
  7. Cobaugh DJ, Gainor C, Gaston CL, Kwong TC, Magnani B, McPherson ML, Painter JT, Krenzelok EP. The opioid abuse and misuse epidemic: Implications for pharmacists in hospitals and health systems. American Journal of Health-System Pharmacy. 2014; 71(18):1539-1554.
  8. Painter JT, Talbert J, Crofford LJ. Geographic variation of chronic opioid use for fibromyalgia. Clinical Therapeutics. 2013; 35(3):303-311.
  9. Painter JT, Crofford, LJ. Chronic opioid use in fibromyalgia: a clinical review. Journal of Clinical Rheumatology. 2013; 19(2):72-77.
  10. Painter JT, Fink III JL. Educational innovations: Categories of bulletin board postings designed to increase awareness of contemporary pharmaceutical policy issues. Pharmacy Practice. 2010; 8(4):255-259.